Elon Musk's brain implant company Neuralink said Wednesday that it now has 21 total participants enrolled in trials worldwide, as it marks two years since it officially began testing in humans.
This marks an increase from the 12 people the company said in September had received its chips and were using them to control digital and physical devices through thought.
The implant is designed to help people with conditions such as spinal cord injury.
The first patient used it to play video games, browse the internet, post on social media and move the cursor on a laptop.
"A key goal of our expanding clinical trials is to better understand these changes and improve both our hardware and the overall procedure for each participant," the company said in a statement.
Neuralink began human trials of its brain implant in 2024 after addressing safety concerns raised by the US Food and Drug Administration, which had initially rejected its application in 2022.
The company said it is working closely with regulatory bodies and hospital sites to provide improved devices to participants and maintain its current record of zero serious adverse events related to the devices. /Telegrafi/
